Cargando…
Postoperative hepatic arterial chemotherapy in high-risk patients as adjuvant treatment after resection of colorectal liver metastases - a randomized phase II/III trial – PACHA-01 (NCT02494973)
BACKGROUND: After curative-intent surgery for colorectal liver metastases (CRLM), liver recurrence occurs in more than 60% of patients, despite the administration of perioperative or adjuvant chemotherapy. This risk is even higher after resection of more than three CRLM. As CRLM are mostly supplied...
Autores principales: | Goéré, Diane, Pignon, Jean-Pierre, Gelli, Maximiliano, Elias, Dominique, Benhaim, Léonor, Deschamps, Frédéric, Caramella, Caroline, Boige, Valérie, Ducreux, Michel, de Baere, Thierry, Malka, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6080555/ https://www.ncbi.nlm.nih.gov/pubmed/30081865 http://dx.doi.org/10.1186/s12885-018-4697-7 |
Ejemplares similares
-
Treatment intensification with hepatic arterial infusion chemotherapy in patients with liver-only colorectal metastases still unresectable after systemic induction chemotherapy – a randomized phase II study -- SULTAN UCGI 30/PRODIGE 53 (NCT03164655)- study protocol
por: Boilève, Alice, et al.
Publicado: (2020) -
Ibrahim Pacha and His Doctor's Bill
Publicado: (1846) -
Primary Colorectal Tumor Displays Differential Genomic Expression Profiles Associated with Hepatic and Peritoneal Metastases
por: Gelli, Maximiliano, et al.
Publicado: (2023) -
Tumour-infiltrating CD68+ and CD57+ cells predict patient outcome in stage II–III colorectal cancer
por: Chaput, N, et al.
Publicado: (2013) -
Molecular targeted therapy of BRAF-mutant colorectal cancer
por: Ducreux, Michel, et al.
Publicado: (2019)